Antibody data
- Antibody Data
- Antigen structure
- References [3]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN2452069 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-Tumor Protein P53 (TP53) (pSer20) antibody
- Antibody type
- Monoclonal
- Antigen
- synthetic peptide containing pSer20
- Description
- Purified
- Reactivity
- Human
- Host
- Mouse
- Epitope
- pSer20
- Isotype
- IgG
- Antibody clone number
- 17B6
- Vial size
- 50 μg
- Storage
- -20 C (For long term storage: -70 C)
Submitted references Post-translational modification of p53 in tumorigenesis.
DNA damage-induced activation of p53 by the checkpoint kinase Chk2.
DNA damage-inducible phosphorylation of p53 at N-terminal sites including a novel site, Ser20, requires tetramerization.
Bode AM, Dong Z
Nature reviews. Cancer 2004 Oct;4(10):793-805
Nature reviews. Cancer 2004 Oct;4(10):793-805
DNA damage-induced activation of p53 by the checkpoint kinase Chk2.
Hirao A, Kong YY, Matsuoka S, Wakeham A, Ruland J, Yoshida H, Liu D, Elledge SJ, Mak TW
Science (New York, N.Y.) 2000 Mar 10;287(5459):1824-7
Science (New York, N.Y.) 2000 Mar 10;287(5459):1824-7
DNA damage-inducible phosphorylation of p53 at N-terminal sites including a novel site, Ser20, requires tetramerization.
Shieh SY, Taya Y, Prives C
The EMBO journal 1999 Apr 1;18(7):1815-23
The EMBO journal 1999 Apr 1;18(7):1815-23
No comments: Submit comment
No validations: Submit validation data